The application of erythrocyte and reticulocyte related indices in anemia and bone marrow transplantation
LI Wei,ZHANG Yan,CHEN Qian,CAI Hao,LI Jian-ying,WU Wei,SHANG Xue-song,YU Hai-fang,YANG Yi-nan,TIAN Jian-wei,ZHANG Jian-ping,LI Shu-lan,CUI Wei
2012-01-01
Abstract:Objective:To establish the reference ranges of Ret-He,Hypo-He%,RBC-He,D-He,FRC%,FRC #,IRF,CHr and Hypo%,and to study their clinical values in differentiating anemia and monitoring bone marrow transplantation.Methods: 401 samples from apparently healthy individuals were tested to establish the reference ranges of Ret-He,Hypo-He%,RBC-He,D-He,FRC%,FRC#,IRF by XE-5000 analyzer and the reference ranges of CHr and Hypo% by Bayer ADVIA 2120 analyzer.Further analyses on all of indices were performed in 105 samples from 52 patients with hypochromic microcytic anemia and 53 patients with macrocytic anemia.The clinical values of Ret-He,CHr,IRF,RBC,HGB,WBC,PLT and Ret% in monitoring hematopoietic recovery were also evaluated in 9 adult patients undergoing bone marrow transplantation.Results: The data of Ret-He,IRF% and CHr were normal distributed,and the reference ranges were 35.5±2.4,9.63±6.7,31.7±1.7,respectively.The data of RBC-He,Hypo-He%,FRC%,FRC#,D-He and Hypo% were non-normal distributed,and the reference ranges were 29.6~33.7,0.1~0.6,0~0.35,0~0.0168,2.0~5.1,0.1~1.8,respectively.Ret-He,RBC-He and CHr decreased in hypochromic microcytic anemia patients,while Hypo-He%,FRC%,IRF and Hypo% increased.In patients with macrocytic anemia,Ret-He,Hypo-He%,RBCHe,D-He,FRC%,FRC#,IRF,CHr and Hypo% all increased.Good linear correlation was found between Ret-He and CHr(r=0.950,P<0.001) and between Hypo-He% and Hypo%(r=0.969,P<0.001).It was observed that IRF first increased in 10d after transplantation and 5d in advance compared with routine parameters,while RBC,HGB,Ret-He and CHr had no change in 25d after transplantation.Conclusion: Ret-He,RBC-He and CHr could be used to differentiate hypochromic microcytic anemia from macrocytic anemia,and IRF could be used to monitor hematopoietic recovery after bone marrow transplantation.